Ipamorelin vs Sermorelin: Which GH Secretagogue Is Right for Your Research?

Ipamorelin and Sermorelin both stimulate GH release from the pituitary, but through entirely different receptor systems.

Sermorelin is a synthetic analogue of GHRH (Growth Hormone-Releasing Hormone) — the natural hypothalamic signal for GH release. It's a 29-amino acid peptide that binds to GHRH receptors on the pituitary. Previously FDA-approved as Geref for diagnosing and treating GH deficiency in children.

Ipamorelin is a synthetic 5-amino acid pentapeptide that mimics ghrelin — the "hunger hormone" that also stimulates GH release. It binds to the GHS-R1a (ghrelin receptor), a completely separate receptor system from Sermorelin's target. Never FDA-approved; remains a research peptide.

Why this matters: Because they work through different receptors, they can be stacked for synergistic GH release. CJC-1295 (a GHRH analogue like Sermorelin) + Ipamorelin is one of the most popular GH secretagogue stacks for this reason.

Sermorelin GH pulse: - Moderate, physiological pulse closely mimicking natural GHRH-stimulated release - Peak around 60 minutes, baseline return within 2–3 hours - Effectiveness depends on pituitary GHRH receptor density — which declines with age - Somatostatin can suppress the response (after meals, during stress)

Ipamorelin GH pulse: - Robust, clean pulse — generally stronger than Sermorelin at equivalent relative doses - Peak around 30–45 minutes, baseline return within 2–3 hours - Called the "cleanest" GH secretagogue — minimal effect on cortisol, prolactin, or ACTH - Less affected by somatostatin inhibition - Consistent response across age groups — ghrelin receptors are better preserved with ageing

Combined pulse (stacking): When a GHRH analogue (CJC-1295 or Sermorelin) is combined with Ipamorelin, the GH response is synergistic — significantly greater than either alone. Two independent pathways activated simultaneously.

Sermorelin: - Injection site reactions (mild, transient) - Facial flushing — relatively common - Occasional mild headache - No significant hunger increase - No cortisol or prolactin elevation - Overall: Well-tolerated, mild profile

Ipamorelin: - Injection site reactions (mild, transient) - Transient head rush immediately after injection (more common than Sermorelin) - Minimal to no appetite increase (far less than GHRP-6 or GHRP-2) - No significant cortisol elevation — its key advantage over other ghrelin-pathway peptides - No significant prolactin elevation - Mild fluid retention in first 1–2 weeks - Overall: Considered the best-tolerated of all GH secretagogues

Both are notably better tolerated than GHRP-2 and GHRP-6, which can significantly raise cortisol, prolactin, and appetite. This is why Ipamorelin has largely replaced GHRP-6 in modern protocols.

Body composition: Ipamorelin — slight advantage. Stronger GH pulse; no appetite increase.

Sleep quality: Ipamorelin — often reported as the most noticeable benefit within the first week. Sermorelin also improves sleep but effects may be more subtle.

Recovery and healing: Both similar. GH supports tissue repair regardless of stimulation pathway.

Anti-ageing: Sermorelin may edge slightly for long-term protocols due to its clinical history and physiological pulse pattern. Ipamorelin equally effective.

For beginners: Ipamorelin is often recommended first — clean side effect profile, strong GH pulse, simple protocol (once daily before bed).

Age considerations: - Under 40: Both produce good responses. Choose based on preference - 40–60: Ipamorelin may be more reliable — ghrelin receptors better preserved than GHRH receptors - Over 60: Ipamorelin generally preferred. Stack with CJC-1295 (no DAC) for dual-pathway compensation

Sermorelin: - Dose: 200–300mcg/day - Timing: Before bed, fasted (2–3 hours) - Cycle: 8–12 weeks on, 4 weeks off - Reconstitution: 5mg vial + 2.5ml bac water = 2,000mcg/ml

Ipamorelin: - Dose: 200–300mcg/day (up to 500mcg in some protocols) - Timing: Before bed, fasted (2–3 hours) - Cycle: 8–12 weeks on, 4 weeks off - Reconstitution: 2mg vial + 2ml bac water = 1,000mcg/ml

Popular stacking protocols:

CJC-1295 (no DAC) + Ipamorelin — gold standard: - CJC-1295: 100mcg + Ipamorelin: 200–300mcg - Combined before bed, fasted - Synergistic dual-pathway GH release

Sermorelin + Ipamorelin: - Sermorelin: 200mcg + Ipamorelin: 200mcg - Combined before bed, fasted - Similar rationale but less commonly used

Cost: Both similarly priced — approximately £60–120 for an 8-week cycle.

| Factor | Ipamorelin | Sermorelin | |---|---|---| | Receptor | GHS-R1a (ghrelin) | GHRH receptor | | GH pulse strength | Strong | Moderate | | Side effects | Minimal (mild head rush) | Minimal (flushing) | | Appetite increase | Minimal | None | | Age resilience | Good (receptor preserved) | Declines with age | | FDA history | Never approved | Previously approved | | Dose | 200–300mcg/day | 200–300mcg/day | | Best stack partner | CJC-1295 (no DAC) | Ipamorelin |

Choose Ipamorelin if: You want the strongest, cleanest GH pulse; you're over 40; you plan to stack with CJC-1295; you're a beginner seeking the most well-characterised secretagogue.

Choose Sermorelin if: You prefer a peptide with FDA approval history; you want the most physiological GH pattern; you're under 40 with healthy pituitary function.

Or stack them: For maximum GH response, combine a GHRH analogue with Ipamorelin for synergistic dual-pathway stimulation.